| Jennifer Garay Gonzalez, | |
|
3803 Pine St, Amarillo, TX 79118-7733 | |
| (806) 290-6736 | |
| Not Available |
| Full Name | Jennifer Garay Gonzalez |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 3803 Pine St, Amarillo, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073286472 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 65485 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Garay Gonzalez, 3803 Pine St, Amarillo, TX 79118-7733 Ph: (806) 290-6736 | Jennifer Garay Gonzalez, 3803 Pine St, Amarillo, TX 79118-7733 Ph: (806) 290-6736 |
News Archive
Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals, received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
In a large clinical trial testing dietary supplements for prostate cancer (PCa) prevention, baseline selenium (Se) status (measured by toenail Se concentration), in the absence of supplementation, was not associated with prostate cancer (PCa) risk.
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the prescription medication Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents ages 13 to 17. The approval is based on study data demonstrating that Vyvanse improved ADHD symptoms compared to placebo in adolescents with ADHD. Vyvanse is also indicated for the treatment of ADHD in children ages 6 to 12 years, and adults.
In a case study of a type of melanoma skin cancer typically found on chronically sun-exposed skin, Saint Louis University researchers found that imiquimod, a topical cream, produced good results for patients when used together with surgery to treat the cancer, potentially helping doctors cut less.
CytomX Therapeutics, a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today entered into a collaboration with The University of Texas MD Anderson Cancer Center to research Probody-enabled chimeric antigen receptor natural killer (CAR-NK) cell therapies, to be known as ProCAR-NK cell therapies.
› Verified 4 days ago
Sara Northrup, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1501 S Polk St, Amarillo, TX 79101 Phone: 806-349-5676 Fax: 806-337-1036 | |
Ms. Melisa Dawn Martinez, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 6010 W Amarillo Blvd, Amarillo, TX 79106 Phone: 806-355-9703 | |
Mrs. Kara Annalise Birch, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6010 W Amarillo Blvd, Amarillo, TX 79106 Phone: 806-355-9703 Fax: 806-356-3811 | |
Jennifer Oliver, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3211 S Coulter St, Amarillo, TX 79106 Phone: 806-584-0494 | |
Cheryl L. Ray, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1901 Medipark, #65, Amarillo, TX 79106 Phone: 806-468-7611 Fax: 806-468-7603 | |
Dakota Devon Lippon, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9525 W Amarillo Blvd, Amarillo, TX 79124 Phone: 806-341-8485 | |
Ms. Rosalinda I Heider, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 6010 Amarillo Boulevard West, Amarillo, TX 79103 Phone: 806-355-9703 |